About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 4

Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction

A Multicenter, Double-Blind Placebo Controlled, Fixed Dose Study With An Open-Label, Flexible Dose Phase To Assess The Efficacy Of Sildenafil Citrate In Providing A Better Sexual Experience Including Quality Of Erections And Satisfaction In Men With Erectile Dysfunction

NCT00245258•Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Impotence

Interventions

Sildenafil Citrate

Locations

19

Russia

Locations (19)

Pfizer Investigational Site

Moscow, Russia

Pfizer Investigational Site

Moscow, Russia

Pfizer Investigational Site

Moscow, Russia

Pfizer Investigational Site

Rostov-on-Don, Russia

Pfizer Investigational Site

Saint Petersburg, Russia

Pfizer Investigational Site

Pusan, South Korea

Key Dates

Start Date

November 1, 2005

Completion Date

September 1, 2006

Last Updated

February 1, 2021

Related Studies

COMPLETEDPhase 2

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

NCT03830164

Male Erectile DisorderProstate Adenocarcinoma+2 more

COMPLETEDPhase 4

QEQ Treatment Responsiveness Evaluation Study

NCT00151463

COMPLETEDPhase 4

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

NCT00301262

Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer

NCT00906269

ImpotenceProstatic Neoplasms

COMPLETEDPhase 1/2

Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction

NCT02472431

Erectile DysfunctionImpotence, Vasculogenic

Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i

NCT00498680

View all related studies

Sponsors

Lead Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 1, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions